Eli Lilly and Company (LLY) vs Oracle Corporation (ORCL)

See how Eli Lilly and Company and Oracle Corporation differ across market data and performance, so you can decide which asset best fits your strategy.

$1,156.73
NYSE
Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.
View Full Page
$149.12
NYSE
Oracle Corporation delivers enterprise applications and infrastructure solutions through flexible IT deployment models, including on-premises, cloud, and hybrid environments. Founded in 1977, Oracle introduced the first commercial SQL-based relational database management system, widely used by many of the world’s largest enterprises for high-volume online transaction processing. In addition to its database products, Oracle offers enterprise resource planning platforms and cloud infrastructure that are becoming increasingly important for large language model training and inference.
View Full Page

Key Metrics Comparison

Eli Lilly and CompanyLLY
Market Cap
$1.032T
Price
$1,156.73
24h Change
-1.52%
24h Volume
$3.03M
Employees
50,000
Shares Outstanding
944,818,881
Oracle CorporationORCL
Market Cap
$429.536B
Price
$149.12
24h Change
-1.15%
24h Volume
$15.66M
Employees
162,000
Shares Outstanding
2,876,046,000

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
LLY
70.6%
ORCL
29.4%

Volume Share

Share of combined 24h volume

Volume Share
LLY
16.2%
ORCL
83.8%

24h Performance

Price change over last 24 hours

24h Performance
LLY
-1.52%
ORCL
-1.15%
Price Comparison
Eli Lilly and Company
Oracle Corporation